Edwards Lifesciences downgrade hits shares

Shares of Edwards Lifesciences slide as an analyst downgrades the company’s stock over concerns a new heart valve isn’t gaining enough acceptance in the medical community.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.